Is a scientist at the INSERM U1026 BioTis unit, specializing in cellular and gene therapies and tissue engineering. Her expertise lies in the end-to-end management of cell banks and she oversees cell culture operations supporting the ART Bioprint platform projects. She is actively involved in the development of 3D cell culture systems based on smart biomaterials for the production of cell models in oncology. Malou is involved in several European and national research projects. She also plays a key role in the ART BioPrint platform, which focuses on advancing bioinks and bioprinting technologies. Through her multidisciplinary and translational approach, Malou is dedicated to advancing cellular therapies, aiming to revolutionize regenerative medicine and improve patient outcomes. She is committed to expanding the impact of medical research by delivering innovative solutions to current clinical challenges and shaping the future of medical practice.
